Skip to the page

Data / Form D filings / RedShift BioAnalytics, Inc.

RedShift BioAnalytics, Inc.: Form D filings

RedShift BioAnalytics, Inc., a technology company in Boxborough, MA, filed 10 Form D notices with the SEC between 2013 and 2025. The latest, on June 26, 2025, reports $5.9 million sold of a $7.1 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
80 Central Street, Boxborough, MA, 01719
Phone
(781) 345-7300
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1349049

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 26, 2025New notice$7,065,195$5,914,304$1,150,8918Jun 12, 2025sec.gov
Apr 3, 2024New notice$7,000,000$5,000,000$2,000,0006Mar 21, 2024sec.gov
Oct 29, 2021New notice$19,999,998$9,999,998$10,000,00012Oct 15, 2021sec.gov
Dec 23, 2020New notice$6,444,632$6,400,511$44,1216Dec 17, 2020sec.gov
Dec 11, 2019Amendment$18,300,000$18,250,000$50,00011Sep 21, 2018sec.gov
Oct 22, 2018New notice$10,000,000$6,000,000$4,000,00011Sep 21, 2018sec.gov
Mar 8, 2017New notice$10,783,718$10,783,71810Feb 22, 2017sec.gov
Oct 2, 2015New notice$2,000,000$998,139$1,001,8614Sep 21, 2015sec.gov
Apr 3, 2014New notice$1,750,000$751,549$998,4514Mar 31, 2014sec.gov
Jan 11, 2013New notice$2,853,639$2,403,639$450,00011Dec 18, 2012sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Frank SmithDirector
William CadoganDirector
Bryson HollimonDirector
Susan HolleranDirector
Wouter MeulemanDirector
Thomas O'LenicExecutive Officer, Director

Other technology companies in Massachusetts that filed recently

Every Form D from the week of Jun 23, 2025 · All recent filings in Massachusetts · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what RedShift BioAnalytics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.